Get all your news in one place.

100's of premium titles.
One app.

Start reading

Get all your news in one place.

100's of premium titles. One news app.

Start reading

UNCOVERED: Longboard pharmaceuticals | History Defined

3 'Strong-Buy'-Rated Russell 2000 Stocks With 54% to 110% Upside

Investing in these small caps could be rewarding in the long run.

Barchart · Aug 9, 2024

5 Breakout Biotech Stocks Leading the Russell 2000 Higher

These small-cap biotech stocks are rallying hard in 2024, and still have room to keep leading the RUT higher.

Barchart · May 23, 2024

Benzinga's Top Ratings Upgrades, Downgrades For April 27, 2022

Benzinga · Apr 27, 2022

From analysis to the latest developments in health,
read the most diverse news in one place.

Longboard Pharmaceuticals: Q1 Earnings Insights

Longboard Pharmaceuticals (NASDAQ:LBPH) reported its Q1 earnings results on Thursday, March 3, 2022 at 04:05 PM. Here's what investors need to know about the announcement.

Benzinga · Mar 4, 2022

Coverage From

Organisations

Capital One Financial

52 stories

Bank of New York Mellon

From analysis to the latest developments in health,
read the most diverse news in one place.

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.